Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.57+0.05 (+9.86%)
Close on Nov 13, 2026Market cap $53.35MP/E –Yield –
Citius Oncology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$5.49M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$5.49M | – |
| FY2022 | Dec 31, 2022 | -$47.97K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$2.71M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$3.83M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$7.35M | – |
See a number that looks wrong?